Corporate Profile

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

 

lnk Overview

Read More

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

lnk Stock Information

View All Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

News Releases

News and views about the Intercure.

16-May-22

InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Record revenue of $3 4 1 million in the first quarter of 2022 Adjusted EBITDA 2 increased almost 1 1 0% year-over-year to $8 million Net income of $ 6 million for the Q1 of 2022 compare d to $ 2 million in Q1 of 2021 Seventh consecutive quarter of positive cash flow from operations $9 1 million
16-May-22

InterCure to Release its Q1 2022 Results and Hold a Conference Call

Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET NEW YORK and TORONTO and HERZLIYA, Israel, May 16, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial
09-May-22

InterCure to Participate in Upcoming Investor Conferences in May 2022

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financial Officer, will

lnk News

Events
Investor events will be posted soon.

lnk Events

View All Events
Featured Reports